London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950
info@mrcplast.com

Our Clients

Order Informer

 
Home > News >
 

SABICs plants got certification to produce FDA-compliant and biocompatible resins

January 16/2012

(Sabic) -- SABICs Innovative Plastics business announced that its manufacturing facilities in Campinas, Brazil and Tortuguitas, Argentina, are now certified to produce U.S. Food and Drug Administration (FDA) - compliant and biocompatible resins for the fast-growing South American healthcare market to help slash lead times, reduce inventory costs and increase flexibility in material purchasing.


Medical markets in eight Latin and South American countries - Brazil, Mexico, Argentina, Chile, Venezuela, Peru, Colombia and Cuba - are expected to demonstrate a compound annual growth rate (CAGR) of 4.6 percent between 2008 and 2013, reaching U.S. USD9.2 billion, according to Espicom Health Intelligence.


To meet this increasing demand, SABIC is committed to providing local customers fast and easy access to high-performance materials - such as biocompatible Lexan HP polycarbonate (PC) resins - and technical resources that they need to bring the next generation of medical applications to market.


mrcplast.com

Author:Marina Ivanova
Tags:Sabic.
Category:General News
|
| More

Leave a comment

MRC help

 


 All News   News subscribe